A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a muscular disease characterized by progressive muscle degeneration. Life expectancy is between 30 and 50 years, and death is correlated with cardiac or respiratory complications. Currently, there is no cure, so there is a great interest in new pharmacological ta...
Main Authors: | Elisa Domi, Malvina Hoxha, Emanuela Prendi, Bruno Zappacosta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/6/1380 |
Similar Items
-
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01) -
Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01) -
Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01) -
Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01)